Q2 Holdings Aktie

Q2 Holdings für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A1XEYE / ISIN: US74736L1098

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
23.07.2025 18:01:01

Alexandria Posts Q2 Revenue Beat

Alexandria Real Estate Equities (NYSE:ARE), a real estate investment trust specializing in life sciences campuses, released its second quarter 2025 results on July 21, 2025. The company reported adjusted funds from operations (a measure used by real estate investment trusts to gauge cash flow available for distributions) of $2.33 per share, far above the $0.59 per share analyst estimate. Revenue arrived at $762 million, topping expectations as well. However, the quarter saw a net loss per share of ($0.64), flipped from last year’s $0.25 profit, primarily due to asset impairment charges. Overall, the quarter displayed strong cost controls and ongoing operational progress, even as the occupancy rate continued to slip and non-cash charges weighed on earnings. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Alexandria Real Estate Equities owns, develops, and operates office and laboratory properties built for the life sciences industry. Its campuses are concentrated in major innovation hubs like Boston, San Diego, and the San Francisco Bay Area. Most of its rental revenue comes from so-called "Megacampus" properties, large-scale campuses clustered in top-tier industry locations.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu Q2 Holdings Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Alexandria Co. for Pharmaceuticals & Chemical Industries 555,50 0,40% Alexandria Co. for Pharmaceuticals & Chemical Industries
Q2 Holdings Inc 77,00 0,65% Q2 Holdings Inc